Docoh
Loading...

ABVC Abvc Biopharma

Filed: 27 Nov 17, 7:00pm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K/A

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 28, 2017 (November 20, 2017)

 

AMERICAN BRIVISION (HOLDING) CORPORATION 
(Exact name of registrant as specified in its charter)

 

Nevada 333-91436 26-0014658
(State or other jurisdiction
of incorporation)
 (Commission File Number) 

(IRS Employer

Identification No.)

 

11 Sawyers Peak Drive, Goshen, NY, 10924

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (845) 291-1291

 

Check the appropriate box below if the Form 8-K/A filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 4.01 CHANGES IN REGISTRANT’S CERTIFYING ACCOUNTANT.

 

On November 27, 2017, American BriVision (Holding) Corporation (the “Company”) filed a Current Report on Form 8-K to disclose that the Company changed its independent registered public accounting firm from Centurion ZD CPA Limited (the “Former Auditor”) to KCCW Accountancy Corp. The Former Auditor has issued its consent letter to the Company stating that it agrees with the disclosure on such Current Report filed with the Securities and Exchange Commission on November 27, 2017.  A copy of the letter from the Former Auditor addressed to the Securities and Exchange Commission dated as of November 28, 2017 is filed as Exhibit 16.1 to this Current Report on Form 8-K/A.

 

Item 9.01. Financial Statements and Exhibits.

 

(d) Exhibits.

 

The exhibit listed in the following Exhibit Index is filed as part of this Current Report on Form 8-K/A.

 

Exhibit No. Description
   
16.1 Centurion ZD CPA Limited’s Letter to the Securities and Exchange Commission dated November 28, 2017

 

 2 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 AMERICAN BRIVISION (HOLDING) CORPORATION
   
 Date: November 28, 2017By:/s/ Howard Doong
 Name: Howard Doong
 Title: Chief Executive Officer

 

 

3